xxiicentury.com - XXII Future Price to Earnings

22nd Century Group (XXII) is developing a unique biotechnological ecosystem, combining hemp cultivation and tobacco modification to create healthier alternatives. The company's forward P/E ratio reflects the business valuation dynamics, where 0.00 shows the current value of the metric. Robotic genomic editing and automated packaging are reducing manual labor, while new management implements rigorous crisis management to restore shareholder confidence.

Projected Price to Earnings Ratio: 22nd Century Group (XXII) for 07/04/2022 - 11/14/2026

Analytical breakdowns for 22nd Century (XXII)

- stock quotes and analyst forecast:

Stock Price 22nd Century Group|XXII - Forecast Levels Chart

- issuer market value details:

Market Value 22nd Century Group Inc.|XXII - Total Enterprise Value

- balance sheet equity data:

Net Assets per Single Share 22nd Century Group|XXII - Total Stockholders' Equity|Market Capitalization to Book Value Ratio xxiicentury.com|XXII - Total Business Assets

- debt level and financial liquidity data:

- company profitability and valuation multiples indicators:

XXII - Net Income|Projected Future Earnings 22nd Century Group|XXII - Market Cap to Earnings|Future Price to Earnings 22nd Century Group|XXII - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio 22nd Century Group Inc.|XXII - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months 22nd Century Group|XXII - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months xxiicentury.com|XXII - Earnings per share increase in current year|Expected earnings per share growth for next year 22nd Century Group

- sales and revenue data:

XXII - Company Total Revenue|Company Future Sales Volume 22nd Century Group|XXII - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple 22nd Century Group Inc.

Summary company analytics:22nd Century Group, Inc.

Forward P/E reflects the market value of an asset relative to expected annual earnings, allowing for an assessment of the premium paid for future growth rates. By analyzing the historical forward P/E ratio of 22nd Century Group (XXII), an investor can see how the market values the potential for implementing innovative nicotine-free tobacco and the strategic alliances of 22nd Century Group (XXII) with industry behemoths, transforming technological expectations into concrete market value.

Who 22nd Century Group competes with